XML 53 R39.htm IDEA: XBRL DOCUMENT v3.19.2
BUSINESS ACQUISITIONS - Narrative (Details)
£ in Millions
3 Months Ended 6 Months Ended
Apr. 29, 2019
USD ($)
Apr. 03, 2018
USD ($)
Jan. 11, 2018
USD ($)
Jun. 29, 2019
USD ($)
Mar. 30, 2019
USD ($)
Mar. 30, 2019
GBP (£)
Jun. 30, 2018
USD ($)
Jun. 29, 2019
USD ($)
Jun. 30, 2018
USD ($)
Sep. 29, 2018
USD ($)
Sep. 29, 2018
GBP (£)
Mar. 26, 2018
USD ($)
Jan. 11, 2018
GBP (£)
Credit facility | $2.3 Billion Credit Facility                          
Business Acquisition [Line Items]                          
Credit facility                       $ 2,300,000,000  
Citoxlab                          
Business Acquisition [Line Items]                          
Purchase price $ 528,100,000                        
Purchase price allocation 491,729,000                        
Goodwill, amount expected to be deductible for tax purposes $ 7,200,000                        
Integration related costs and transaction costs       $ 12,100,000       $ 17,200,000          
Actual revenue from acquiree       30,900,000                  
Actual earnings from acquiree       2,000,000.0                  
Weighted average amortization life of intangible assets acquired 12 years                        
Citoxlab | Client relationships                          
Business Acquisition [Line Items]                          
Weighted average amortization life of intangible assets acquired 13 years                        
MPI Research                          
Business Acquisition [Line Items]                          
Purchase price   $ 829,700,000                      
Purchase price allocation $ 491,700,000 800,800,000                      
Cash acquired $ 36,400,000 27,700,000                      
Goodwill, amount expected to be deductible for tax purposes   4,100,000                      
Integration related costs and transaction costs       0     $ 11,700,000 $ 0 $ 14,500,000        
Adjustments related to prior period   $ 1,200,000                      
Weighted average amortization life of intangible assets acquired   12 years                      
MPI Research | Client relationships                          
Business Acquisition [Line Items]                          
Weighted average amortization life of intangible assets acquired   13 years                      
KWS BioTest Limited                          
Business Acquisition [Line Items]                          
Purchase price     $ 20,300,000                    
Purchase price allocation     21,529,000                    
Cash acquired     1,000,000.0                    
Integration related costs and transaction costs       $ 0     $ 0   500,000        
Adjustments related to prior period     $ 400,000                    
Undiscounted contingent payments                   $ 2,600,000 £ 2.0   £ 3.0
Payments for contingent liabilities         $ 2,600,000 £ 2.0              
KWS BioTest Limited | Client relationships                          
Business Acquisition [Line Items]                          
Weighted average amortization life of intangible assets acquired               12 years          
Depreciation and Amortization Expense | Citoxlab                          
Business Acquisition [Line Items]                          
Adjustments related to prior period               $ 4,000,000.0 5,100,000        
Depreciation and Amortization Expense | MPI Research                          
Business Acquisition [Line Items]                          
Adjustments related to prior period                 9,400,000        
Interest expense | Citoxlab                          
Business Acquisition [Line Items]                          
Adjustments related to prior period               $ 1,200,000 2,000,000.0        
Interest expense | MPI Research                          
Business Acquisition [Line Items]                          
Adjustments related to prior period                 $ 2,800,000